Quezada, Julio
Coffman, Keith A.
Article History
First Online: 15 January 2018
Compliance with Ethical Standards
:
: The funding for this publication and paying the fee for this publication to be made open access is from internal research funding granted to Keith A. Coffman, M.D. from the Department of Pediatrics at Children’s Mercy Hospital, Kansas City.
: Julio F. Quezada, MD, has no conflicts to report. Keith A. Coffman, MD, is the Co-Chair of the Tourette Association of America Medical Advisory Board. He has also received honoraria for lectures given on behalf of the Tourette Association of America, but the content of those lectures is original and not reviewed or edited by the Tourette Association of America. Dr. Coffman has been a site Primary Investigator for a multi-center, randomized, placebo-controlled crossover trial of ecopipam for the treatment of Tourette syndrome, sponsored by Psyadon Pharmaceuticals, Inc.